An international team of researchers experimenting with the function of the endocannabinoid system have shown how it can be manipulated to combat obesity with the help of a synthetic peptide. The studies carried out on mice demonstrate how the treatment can prevent weight gain and keep diabetes at…| New Atlas
Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost fitness and can cause serious muscle loss, potentially undermining the long-term health benefits of slimming down.| New Atlas
Research continues to shine a light on all the surprising ways that exercise can benefit the human body, and that includes altering the composition of our gut microbiome and tempering inflammation. A new study has explored this phenomenon in sufferers of arthritis, and shown how the cannabis-like…| New Atlas
The US Food and Drug Administration (FDA) has instructed all GLP-1 drug-makers to update their warning labels to include the risk of serious kidney injury that can result from dehydration. This comes after people taking the medication for either obesity or diabetes have needed to undergo…| New Atlas
